<?xml version="1.0" encoding="UTF-8"?>
<p>Previously, it was shown that, either in severe influenza or SARS-CoV infection, convalescent plasma treatment could significantly decrease viral load and reduce the mortality 
 <xref rid="B31" ref-type="bibr">31</xref>, 
 <xref rid="B36" ref-type="bibr">36</xref>. Convalescent plasma has been used for severe SARS-CoV-2 infection in China 
 <xref rid="B22" ref-type="bibr">22</xref>, although promising, the efficacy and safety need to be carefully further evaluated.
</p>
